Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4120781
Reference Type
Journal Article
Title
Effects of high dose corticosteroids in patients with septic shock: prospective, controlled study
Author(s)
Sprung, CL; Caralis, PV; Marcial, EH; Pierce, M; Karpf, M; Et al
Year
1984
Is Peer Reviewed?
1
Journal
New England Journal of Medicine
ISSN:
0028-4793
EISSN:
1533-4406
Report Number
IPA/85/625079
Volume
Engl
Issue
REF 29
Page Numbers
1137-1143
Language
English
Abstract
IPA COPYRIGHT: ASHP To determine whether corticosteroids are efficacious in severe septic shock, a prospective study was conducted on 59 patients randomly assigned to intravenous injection of 30 mg/kg of methylprednisolone sodium succinate (I), 6 mg/kg of dexamethasone sodium phosphate (II), or control group, 17.5 +- 5.4 h after the onset of shock. Four (19%) of 21 I-treated, 7 (32%) of 22 II-treated, and none of the 16 control patients had reversal of shock 24 h after drug administration. Patients treated with corticosteroids within 4 h after the onset of shock had a higher incidence of shock reversal. At 133 h after drug administration, 17 (40%) of 43 corticosteroid-treated patients and 11 (69%) of 16 control patients died. The differences in reversal of shock and survival disappeared later in the course. Overall, 16 (76%) of 21 patients receiving I, 17 (77%) of 22 patients receiving II and 11 (69%) of 16 controls in the hospital died. It was concluded that corticosteroids do not improve the overall survival of patients with severe, late septic shock but may be helpful early in the course and in certain subgroups of patients.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity